Enfusion Inc
Enfusion, Inc. provides software-as-a-service solutions for investment management industry in the United States, Europe, the Middle East, Africa, and the Asia Pacific. The company offers Portfolio Management System, which generates a real-time investment book of record that consists of valuation and risk tools, which allows users to analyze aggregated or decomposed portfolio data for chief invest… Read more
Enfusion Inc (ENFN) - Net Assets
Latest net assets as of December 2024: $99.54 Million USD
Based on the latest financial reports, Enfusion Inc (ENFN) has net assets worth $99.54 Million USD as of December 2024.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($143.26 Million) and total liabilities ($43.72 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $99.54 Million |
| % of Total Assets | 69.48% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 21.97 |
Enfusion Inc - Net Assets Trend (2019–2024)
This chart illustrates how Enfusion Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Enfusion Inc (2019–2024)
The table below shows the annual net assets of Enfusion Inc from 2019 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $99.54 Million | +28.47% |
| 2023-12-31 | $77.48 Million | -25.10% |
| 2022-12-31 | $103.44 Million | +6.16% |
| 2021-12-31 | $97.44 Million | +141.72% |
| 2020-12-31 | $-233.56 Million | -98.13% |
| 2019-12-31 | $-117.88 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Enfusion Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 1438.4% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $129.00K | 0.18% |
| Other Comprehensive Income | $-734.00K | -1.00% |
| Other Components | $243.94 Million | 333.15% |
| Total Equity | $73.22 Million | 100.00% |
Enfusion Inc Competitors by Market Cap
The table below lists competitors of Enfusion Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
MNC Studios International Tbk PT
JK:MSIN
|
$498.57 Million |
|
Johns LYNG Group Ltd
AU:JLG
|
$498.59 Million |
|
Shanghai Datun Energy Resources Co Ltd
SHG:600508
|
$498.68 Million |
|
Park Aerospace Corp
NYSE:PKE
|
$498.71 Million |
|
SunOpta Inc.
NASDAQ:STKL
|
$498.43 Million |
|
Guangzhou Haoyun Security Technologies Co Ltd
SHE:300448
|
$498.11 Million |
|
Lungyen Life Service
TWO:5530
|
$498.10 Million |
|
CStone Pharmaceuticals
PINK:CSPHF
|
$497.91 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Enfusion Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 53,666,000 to 73,221,000, a change of 19,555,000 (36.4%).
- Net income of 2,823,000 contributed positively to equity growth.
- Other comprehensive income decreased equity by 328,000.
- Other factors increased equity by 17,060,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $2.82 Million | +3.86% |
| Other Comprehensive Income | $-328.00K | -0.45% |
| Other Changes | $17.06 Million | +23.3% |
| Total Change | $- | 36.44% |
Book Value vs Market Value Analysis
This analysis compares Enfusion Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 19.04x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2019-12-31 | $-1.04 | $10.76 | x |
| 2020-12-31 | $-2.07 | $10.76 | x |
| 2021-12-31 | $0.84 | $10.76 | x |
| 2022-12-31 | $0.76 | $10.76 | x |
| 2023-12-31 | $0.41 | $10.76 | x |
| 2024-12-31 | $0.57 | $10.76 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Enfusion Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 3.86%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 1.40%
- • Asset Turnover: 1.41x
- • Equity Multiplier: 1.96x
- Recent ROE (3.86%) is above the historical average (-85.96%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2019 | 0.00% | 21.44% | 2.54x | 0.00x | $24.44 Million |
| 2020 | 0.00% | 5.10% | 2.03x | 0.00x | $27.42 Million |
| 2021 | -510.45% | -252.68% | 1.05x | 1.92x | $-287.77 Million |
| 2022 | -20.40% | -8.82% | 1.21x | 1.90x | $-19.76 Million |
| 2023 | 11.23% | 3.45% | 1.60x | 2.03x | $658.40K |
| 2024 | 3.86% | 1.40% | 1.41x | 1.96x | $-4.50 Million |
Industry Comparison
This section compares Enfusion Inc's net assets metrics with peer companies in the Software - Application industry.
Industry Context
- Industry: Software - Application
- Average net assets among peers: $1,166,100,419
- Average return on equity (ROE) among peers: -60.09%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Enfusion Inc (ENFN) | $99.54 Million | 0.00% | 0.44x | $498.44 Million |
| Abaxx Technologies Inc (ABXXF) | $-1.66 Million | 0.00% | 0.00x | $201.28 Million |
| Acceleware Ltd (ACWRF) | $494.24K | -556.36% | 1.94x | $8.62 Million |
| Adobe Systems Incorporated (ADBE) | $4.65 Billion | 15.57% | 0.23x | $100.66 Billion |
| Adcore Inc (ADCOF) | $-3.18 | 0.00% | 0.00x | $3.03 Million |
| ADEIA CORP (ADEA) | $446.70 Million | -41.54% | 0.09x | $2.48 Billion |
| Automatic Data Processing Inc (ADP) | $6.01 Billion | 20.87% | 4.70x | $83.68 Billion |
| Autodesk Inc (ADSK) | $569.21 Million | 5.60% | 0.55x | $48.93 Billion |
| Allied Security Innovations Inc (ADSV) | $-23.08 Million | 0.00% | 0.00x | $0.98 |
| AudioEye Inc (AEYE) | $9.44 Million | -45.08% | 2.15x | $48.56 Million |
| Affinity Networks Inc (AFFN) | $-470.19K | 0.00% | 0.00x | $0.96 |